摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[Ni(4-furopyridine)2(acetate)2(H2O)2] | 919080-93-6

中文名称
——
中文别名
——
英文名称
[Ni(4-furopyridine)2(acetate)2(H2O)2]
英文别名
——
[Ni(4-furopyridine)2(acetate)2(H2O)2]化学式
CAS
919080-93-6
化学式
C18H20N2NiO8
mdl
——
分子量
451.055
InChiKey
QSNFQGHILOZVNA-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为产物:
    参考文献:
    名称:
    Heteroleptic nickel(II) complexes formed from N-donor bases, carboxylic acids and water: Magnetostructural correlations
    摘要:
    Nickel(II) complexes with the general formula [Ni(L-1)(2)(L-2)(2)(H2O)(2)], where L-1 = 2-methylimidazole (Meiz), 1,2-dimethylimidazole We(2)iz), iso-quinoline (iqu) and 4-furopyridine (fupy), L-2 = formate and acetate, have been prepared and characterized. The structures of four complexes [Ni(MeiZ)(2)(HCOO)(2)(H2O)(2)] (1), [Ni(Me(2)iz)(2)(HCOO)(2)(H2O2] (2), [Ni(iqu)(2)(CH3COO)(2)(H2O)(2)] (3) and [Ni (fupy)(2)(CH3COO)(2)(H2O)(2)] (4) were determined by X-ray diffraction methods. The chromophore of these compounds, {NiO2O'N-2(2)}, is formed by four oxygen atoms and two nitrogen atoms. The structures of complexes 2, 3 and 4 are formed by two-dimensional networks which consist of individual molecules linked together by O-(HO)-O-... hydrogen bonds from carboxylate groups to aqua ligands. In complex 1, the formation of a three-dimensional network is supplemented by N-(HO)-O-..., hydrogen bonds from the coordinated oxygen atom to the secondary nitrogen atom of an imidazole molecule from another unit. All complexes show magnetic behavior typical for zero-field splitting systems. The axial parameter of the zero-field splitting, D, adopts moderate-negative values and it correlates with the axial distortion of the coordination polyhedron. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.poly.2006.05.040
点击查看最新优质反应信息

同类化合物

顺式六氢呋喃[2,3-C]吡咯 顺式-六氢呋喃并[3,4-C]吡咯 甲基4-甲基-4H-呋喃并[3,2-b]吡咯-5-羧酸酯 氮杂环丁烷并[1,2-a]呋喃并[2,3-c]吡咯 夫沙瑞汀A 呋喃并吡咯甲酸 吡喃并[3,4-b]吡咯-2,7-二羧酸,1-乙酰基-1,5-二氢-5-羰基-,二乙基酯 六氢-1H-呋喃并[3,4-c]吡咯 六氢-1H-呋喃并[3,4-C]吡咯 八氢-呋喃并[3,2-c]吡啶 乙基4,6-二氢-5H-呋喃并[2,3-c]吡咯-5-羧酸酯 6H-呋喃并[2,3-b]吡咯-5-羧酸甲酯 6-甲基-6H-呋喃并[2,3-b]吡咯-5-羧酸 6-甲基-6H-呋喃并[2,3-b]吡咯-5-甲酰肼 5-(叔-丁氧羰基)-5,6-二氢-4H-呋喃并[2,3-C]吡咯-3-羧酸 4H-呋喃并[3,2-b]吡咯-5-羧酸乙酯 4H-呋喃并[3,2-b]吡咯-5-羧酸,2-甲酰基-,甲基酯 4H-呋喃并[3,2-b]吡咯 4H-呋喃并[3,2-B!吡咯-5-羧酸甲酯 4-甲基呋喃[3,2-b]吡咯-5-羧酸乙酯 4-甲基-4H-呋喃并[3,2-b]吡咯 4-甲基-4H-呋喃并[3,2-B]吡咯-5-甲酸 365-苄基六氢-1H-呋喃[34-c]吡咯 3-溴-4H-呋喃并[3,2-b]吡咯-5-羧酸 3-溴-4H-呋喃并[3,2-b]吡咯-5-甲酸乙酯 2-苯基-4H-呋喃并[3,2-b]吡咯-5-羧酸 2-甲酰基-6-甲基-6H-呋喃并[2,3-b]吡咯-5-羧酸 2-甲酰基-4-甲基-4H-呋喃并[3,2-b]吡咯-5-羧酸甲酯 2-甲基-4H-呋喃并[3,2-b]吡咯-5-羧酸甲酯 2-甲基-4H-呋喃并[3,2-b]吡咯-5-羧酸乙酯 2-甲基-4H-呋喃并[3,2-b]吡咯-5-羧酸 2-溴-4H-呋喃并[3,2-b]吡咯-5-羧酸乙酯 2-溴-4H-呋喃并[3,2-B]吡咯-5-羧酸 2-(4-甲氧基苯基)-4H-呋喃并[3,2-b]吡咯-5-羧酸乙酯 2-(4-甲氧基苯基)-4H-呋喃并[3,2-b]吡咯-5-羧酸 2,3,3A,4-四氢-5H-呋喃并[3,2-b]吡咯-5-酮 1-(4H-呋喃并[3,2-b]吡咯-4-基)乙酮 1-(2-甲基-4H-呋喃并[3,2-b]吡咯-4-基)乙酮 (9ci)-1-甲基-1H-呋喃并[3,4-b]吡咯-4,6-二酮 (5S)-6,6-二甲基-5-苄基-3-吗啉酮 (4-甲基-4H-呋喃并[3,2-b]吡咯-5-基)甲醇 (3aR,6aR)-4-乙酰基六氢-2H-呋喃并[3,2-b]吡咯-2-酮 (3AS,6AS)-六氢-2H-呋喃并[2,3-C]吡咯盐酸 4-(4-(4-methoxy-1H-pyrazolo[4,3-c]pyridin3-yl)pyridin-2-yl)-2,6-dimethylmorpholine 6-(N-Methyl-N-propargyl-aminomethyl)-benzofuran [Cu(2-(benzo[d]oxazol-2-yl)-4-iodophenol(1-))2] (3aR,6R,9R,10aR,10bS)-1,3-dioxo-6-pentyl-2,3,3a,4,6,8,9,10,10a,10b-decahydro-1H-oxepino[4,3-e]isoindol-9-yl morpholine-4-carboxylate 2,3,5-Trimethyl-7H-furo[2',3':4,5]pyrrolo[1,2-d][1,2,4]triazine-8-thione (3S*,4R*)-4-allyl-1-tert-butyldimethylsilyl-3-(4-methyl-2-oxo-1,3-dioxolan-4-yl)-2-azetidinone (2aR,4aS,5R,8R,8aR,8bS,12aS)-8-(tert-butyldimethylsiloxy)decahydro-5-hydroxy-2,2,4a-trimethyl-9H,12aH-naphtho[1',2':3,4]furo[2,3-b]pyran-4(2H)-one